Streetbeat News

Price Targets

DAN

JP Morgan analyst Ryan Brinkman has maintained an Overweight rating on Dana Inc. (NYSE:DAN) but reduced the price target from $21 to $19.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:31 am

VCEL

Truist Securities analyst Samuel Brodovsky has upgraded Vericel (NASDAQ:VCEL) from Hold to Buy and increased the price target from $39 to $51.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:30 am

BWA

JP Morgan analyst Ryan Brinkman has maintained an Overweight rating on BorgWarner (NYSE:BWA) but reduced the price target from $59 to $52.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:28 am

ALTI

Raymond James analyst Wilma Burdis has upgraded AlTi Global (NASDAQ:ALTI) from Market Perform to Strong Buy and set a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:28 am

APTV

JP Morgan analyst Ryan Brinkman has maintained an Overweight rating on Aptiv (NYSE:APTV) but reduced the price target from $135 to $115. This adjustment reflects a more conservative valuation of the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:25 am

AL

Barclays analyst Mark Devries has maintained an Overweight rating on Air Lease (NYSE:AL) and increased the price target from $46 to $48.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:21 am

CVLG

TD Cowen analyst Jason Seidl upgraded Covenant Logistics Gr (NASDAQ:CVLG) from Market Perform to Outperform and increased the price target from $51 to $66.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:20 am

AER

Barclays analyst Mark Devries has maintained an Overweight rating on AerCap Holdings (NYSE:AER) and increased the price target from $80 to $84.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:18 am

RMD

Needham analyst Mike Matson has maintained a Buy rating on ResMed (NYSE:RMD) and increased the price target from $180 to $215.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:12 am

CORZ

HC Wainwright & Co. analyst Kevin Dede has upgraded Core Scientific (NASDAQ:CORZ) from Neutral to Buy and set a price target of $5 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 11:10 am